Adverse reactions reported in at least 1% of REPATHA-treated patients, and more frequently than in placebo-treated patients, are shown in Table 2
Retatrutide emerges as particularly promising because it addresses these critical metabolic and cellular disturbances head-on through its unique triple-receptor mechanism
Plan warm meals during craving weeks
A variety of tests of may be used to rule out other causes of recurrent nausea and vomiting
Lower activity levels may reduce daily calorie expenditure, highlighting the importance of choosing an exercise routine that matches your energy levels and overall health
Some patients may benefit from a gradual dose increase, while others simply need to improve protein intake, hydration, strength training, or sleep quality